Protein Phosphatase Regulation of the Principal Renal Sodium Transporter NHE3

主要肾钠转运蛋白 NHE3 的蛋白磷酸酶调节

基本信息

  • 批准号:
    8663893
  • 负责人:
  • 金额:
    $ 8.68万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-09-15 至 2016-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Dr. Ion Alexandru Bobulescu is a physician-scientist recently appointed to a full-time faculty position at the instructor level at the University of Texas Southwestern Medical Center at Dallas (UT Southwestern). His short-term career goals (next 4 years) are to rigorously pursue the training and career development plan outlined in this K01 application, perform the proposed experiments using both established and highly innovative techniques to define the role of Protein Phosphatase 2A (PP2A) in the regulation of renal sodium/proton exchange, and then apply for funding under the R01 mechanism to explore one or more of the scientific opportunities derived from this work. Dr. Bobulescu's long-term career goal is to be a leader and innovator in the field of renal regulation of sodium and blood pressure homeostasis, using pioneering approaches and techniques to address fundamental unanswered questions from molecule to model organism to human disease. To achieve these goals, a thorough and detailed Career Development Plan is proposed to address the following training requirements: (1) COURSEWORK. Additional formal training in several areas is considered critical for the advancement of the candidate's research. (2) ADVANCED TECHNIQUES. Working with his mentor and expert collaborators on a hands-on basis to address the Aims of this proposal, Dr. Bobulescu will learn several novel, state-of-the-art methods, and will gain the ability to apply these techniques for his own research questions. (3) MENTORED CAREER DEVELOPMENT. Dr. Bobulescu's chances of achieving relevant results in the new and understudied field of signal transduction via protein phosphatases will greatly benefit from having an expert mentor who will directly guide, supervise and evaluate his research. The mentor for this K01, Dr. Marc Mumby, is a world-renowned expert in protein phosphatase research. In addition, Dr. Bobulescu is aware of the fact that a successful independent career requires much more than ideas, technical skills, and a good track record of publications. Running a research laboratory, managing and nurturing people, fostering collaborations, being an effective mentor and teacher, and being able to maintain a strong and productive research program resulting in successful funding beyond the first R01, are all formidable endeavors- but vital for true academic success. The candidate is certain that he has a lot to learn in these areas from Dr. Mumby, a leading scientist and ideal mentor for this K01. (4) DEPARTMENT. The disease-oriented perspective offered by Dr. Bobulescu's previous postdoctoral research training in a clinical department has been very important for his formation as a physician scientist. However, his training would greatly benefit from a period of immersive exposure to the vastly different environment of a leading basic science department. ENVIRONMENT: UT Southwestern is one of the world's foremost research institutions, with four Nobel prize winners, 36 members of the National Academy of Sciences and/or its Institute of Medicine, more than 3,500 research projects under way with more than $400 million in annual funding, as well as more than 582,000 sq ft of research space with more under construction. Dr. Bobulescu will train primarily in the laboratory of Dr. Marc Mumby in the Department of Pharmacology, including over 2,000 sq ft of total laboratory space, well equipped with all necessary items needed to carry out biochemical, molecular biological, and cell biological experiments. Dr. Bobulescu will also retain his 250 sq ft laboratory space, private 90 sq ft office and faculty position in the Department of Internal Medicine. The candidate will have access to UT Southwestern's state of the art animal research facility, as well as to the UT Southwestern George M. O'Brien Kidney Research Core Center. UT Southwestern has a tradition of retaining the best postdoctoral fellows and fostering their independent careers. This tradition includes the candidate's former mentor, Dr. Orson Moe, who was a postdoctoral fellow at UT Southwestern until 1990 and has remained there ever since, rising to full Professor and Center Director. RESEARCH: This proposal will study the role of PP2A in the regulation of the principal renal sodium transporter NHE3, with special emphasis on the regulation of NHE3 by intra-renal dopamine. If the proposed hypotheses are correct, PP2A will be established as a major regulator of intrarenal dopamine action and of NHE3. This will have a direct impact on our understanding of the physiology and pathophysiology of blood pressure regulation, since impaired dopamine-mediated natriuresis has been described in hypertensive humans, has been attributed to defective intra-renal dopamine signaling in two rodent models of hypertension, and has been linked to defective renal PP2A function. The proposal includes three independent aims that will be pursued simultaneously using a variety of techniques. Aim 1 will use cell culture and in vitro experiments to test whether the inhibition of NHE3 by dopamine requires the direct action of PP2A on NHE3. Aim 2 will use cell culture, biochemistry and advanced electrophysiological techniques to test whether dephosphorylation of NHE3 by PP2A acts as an intracellular switch determining the fate of NHE3. Aim 3 will use advanced in vivo imaging and immunohistochemistry to test whether the inhibition of NHE3 in vivo by physiologic stimuli involves NHE3 dephosphorylation by PP2A. By proposing to uncover the molecular details of a signaling pathway that, when impaired, has been implicated in the pathogenesis of hypertension, this project is clearly relevant to the mission of NIDDK to support research on the most serious diseases affecting public health.
描述(由申请人提供):Ion Alexandru Bobulescu博士是一名医生,科学家,最近被任命为达拉斯(UT西南)德克萨斯大学西南医学中心讲师级的全职教师职位。他的短期职业目标(未来4年)将严格执行本K 01申请中概述的培训和职业发展计划,使用已建立和高度创新的技术进行拟议的实验,以确定蛋白磷酸酶2A(PP 2A)在肾钠/质子交换调节中的作用,然后根据R 01机制申请资金,以探索这项工作所带来的一个或多个科学机会。Bobulescu博士的长期职业目标是成为钠和血压稳态的肾脏调节领域的领导者和创新者,使用开创性的方法和技术来解决从分子到模式生物到人类疾病的基本未回答的问题。为了实现这些目标,提出了一个全面和详细的职业发展计划,以满足以下培训要求:(1)课程。在几个领域的额外正式培训被认为是候选人的研究进步的关键。(2)先进的技术。Bobulescu博士将与他的导师和专家合作者在实践的基础上解决这个提案的目标,他将学习几种新颖的,最先进的方法,并将获得将这些技术应用于他自己的研究问题的能力。(3)指导职业发展。Bobulescu博士在通过蛋白磷酸酶进行信号转导的新的和未充分研究的领域取得相关成果的机会将大大受益于有一个专家导师谁将直接指导,监督和评估他的研究。K 01的导师Marc Mumby博士是世界知名的蛋白磷酸酶研究专家。此外,Bobulescu博士意识到,一个成功的独立职业生涯需要的不仅仅是想法,技术技能和良好的出版记录。运营研究实验室、管理和培养人员、促进合作、成为一名有效的导师和教师,以及能够维持强大且富有成效的研究计划,从而在第一个R 01之后成功获得资金,这些都是艰巨的努力,但对于真正的学术成功至关重要。候选人确信他在这些领域有很多东西要从Mumby博士那里学习,Mumby博士是一位领先的科学家和K 01的理想导师。(4)部门Bobulescu博士以前在临床部门进行的博士后研究培训所提供的以疾病为导向的观点对他成为一名医生科学家非常重要。然而,他的训练将大大受益于一段时间的沉浸式暴露在一个领先的基础科学部门的巨大不同的环境。 环境:UT Southwestern是世界上最重要的研究机构之一,拥有四位诺贝尔奖获得者,36位美国国家科学院和/或其医学研究所的成员,正在进行的研究项目超过3,500个,年度资金超过4亿美元,以及超过582,000平方英尺的研究空间,还有更多正在建设中。Bobulescu博士将主要在药理学系Marc Mumby博士的实验室进行培训,包括超过2,000平方英尺的总实验室空间,配备了进行生化,分子生物学和细胞生物学实验所需的所有必要物品。 Bobulescu博士还将保留他250平方英尺的实验室空间,90平方英尺的私人办公室和内科系的教职。候选人将有机会获得UT西南的最先进的动物研究设施的状态,以及UT西南乔治M。奥布莱恩肾脏研究核心中心。UT西南有保留最好的博士后研究员和培养他们的独立职业的传统。 这一传统包括候选人的前导师,奥森博士莫伊,谁是在UT西南博士后研究员,直到1990年,并一直留在那里至今,上升到教授和中心主任。 研究:该提案将研究PP 2A在调节主要肾钠转运蛋白NHE 3中的作用,特别强调肾内多巴胺对NHE 3的调节。如果所提出的假设是正确的,PP 2A将被确立为肾内多巴胺作用和NHE 3的主要调节剂。这将对我们理解血压调节的生理学和病理生理学产生直接影响,因为在高血压人群中已经描述了多巴胺介导的尿钠排泄受损,这归因于两种啮齿动物高血压模型中肾内多巴胺信号传导缺陷,并且与肾PP 2A功能缺陷有关。该提案包括三个独立的目标,将使用各种技术同时追求。目的1将使用细胞培养和体外实验来测试多巴胺对NHE 3的抑制是否需要PP 2A对NHE 3的直接作用。目的2将使用细胞培养、生物化学和先进的电生理技术来测试PP 2A对NHE 3的去磷酸化是否作为决定NHE 3命运的细胞内开关。目的3将使用先进的体内成像和免疫组织化学来测试生理刺激对体内NHE 3的抑制是否涉及PP 2A对NHE 3的去磷酸化。通过提议揭示信号通路的分子细节,当受损时,与高血压的发病机制有关,该项目显然与NIDDK的使命有关,以支持对影响公共卫生的最严重疾病的研究。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ion Alexandru Bobulescu其他文献

Ion Alexandru Bobulescu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ion Alexandru Bobulescu', 18)}}的其他基金

Role of gut bacteria and renal lipids in obesity-related kidney disease
肠道细菌和肾脂质在肥胖相关肾脏疾病中的作用
  • 批准号:
    9752559
  • 财政年份:
    2017
  • 资助金额:
    $ 8.68万
  • 项目类别:
Role of gut bacteria and renal lipids in obesity-related kidney disease
肠道细菌和肾脂质在肥胖相关肾脏疾病中的作用
  • 批准号:
    9398774
  • 财政年份:
    2017
  • 资助金额:
    $ 8.68万
  • 项目类别:
Protein Phosphatase Regulation of the Principal Renal Sodium Transporter NHE3
主要肾钠转运蛋白 NHE3 的蛋白磷酸酶调节
  • 批准号:
    8329702
  • 财政年份:
    2011
  • 资助金额:
    $ 8.68万
  • 项目类别:
Protein Phosphatase Regulation of the Principal Renal Sodium Transporter NHE3
主要肾钠转运蛋白 NHE3 的蛋白磷酸酶调节
  • 批准号:
    8190315
  • 财政年份:
    2011
  • 资助金额:
    $ 8.68万
  • 项目类别:
Protein Phosphatase Regulation of the Principal Renal Sodium Transporter NHE3
主要肾钠转运蛋白 NHE3 的蛋白磷酸酶调节
  • 批准号:
    8464083
  • 财政年份:
    2011
  • 资助金额:
    $ 8.68万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 8.68万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.68万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 8.68万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.68万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 8.68万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.68万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 8.68万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 8.68万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 8.68万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.68万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了